Precipio, Inc. (NASDAQ:PRPO – Get Free Report) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $5.86 and traded as high as $6.81. Precipio shares last traded at $6.54, with a volume of 9,360 shares trading hands.
Precipio Stock Performance
The stock’s 50 day simple moving average is $5.94 and its two-hundred day simple moving average is $5.86. The company has a debt-to-equity ratio of 0.03, a current ratio of 0.73 and a quick ratio of 0.59. The company has a market capitalization of $9.71 million, a P/E ratio of -1.92 and a beta of 1.41.
Precipio (NASDAQ:PRPO – Get Free Report) last announced its quarterly earnings data on Tuesday, August 13th. The biotechnology company reported ($0.83) earnings per share for the quarter. Precipio had a negative return on equity of 39.66% and a negative net margin of 22.90%. The firm had revenue of $4.44 million for the quarter.
Precipio Company Profile
Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.
Further Reading
- Five stocks we like better than Precipio
- 3 Tickers Leading a Meme Stock Revival
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Differences Between Momentum Investing and Long Term Investing
- MarketBeat Week in Review – 9/23 – 9/27
- The Risks of Owning Bonds
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.